vimarsana.com

Latest Breaking News On - Oncology program - Page 21 : vimarsana.com

BASECAMP-1 Aims to Identify Patients Eligible for Treatment With Novel CAR T-Cell Agent

Looking to replicate the impressive findings with CAR T-cell therapies observed in patients with hematologic malignancies, investigators have initiated the BASECAMP-1 trial, with the hope of identifying patients with advanced solid tumors who will be suitable candidates for treatment in a subsequent trial evaluating the investigational agent A2B530.

Free mouth, head, and neck cancer screenings April 18 at The Dorcy Cancer Center in Pueblo

Free mouth, head, and neck cancer screenings April 18 at The Dorcy Cancer Center in Pueblo
krdo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from krdo.com Daily Mail and Mail on Sunday newspapers.

ACC to host annual Advancing the Cardiovascular Care of the Oncology Patient course

Scientists create mouse avatars to treat mult

An international group of researchers, led by Dr. José Ángel Martínez-Climent at the Cima University of Navarra (Spain), has created mouse avatars of patients with multiple myeloma to study and develop personalized treatments against this blood cancer, the second most frequent hematological cancer and incurable in most cases. These artificial mice can mimic the genetic and immunological diversity of the origin and evolution of this disease in patients. This advance will allow researchers to design more effective and personalized therapies for multiple myeloma. Nature Medicine publishes this study that opens a pathway for research into other non-curable hematological and solid tumors.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.